Back to results
US 8,946,219 B2Granted
Combination therapy with a compound acting as a platelet ADP receptor inhibitor
AssigneePortola Pharmaceuticals, Inc.
InventorsPamela B. Conley, Patrick Andre, Uma Sinha
Life of this patent
Estimating the term…
Abstract
The present invention is directed to pharmaceutical compositions and methods of using combination therapies containing [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea, or a pharmaceutically acceptable salt thereof, for the treatment of thrombosis diseases.
Claims13
A method for treating a condition in a mammal characterized by undesired thrombosis comprising administering to said mammal a therapeutically effective amount of the following therapeutic agents:
- or a pharmaceutically acceptable salt thereof;
- and
- (2) betrixaban or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.